diethylstilbestrol has been researched along with epirubicin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dunzendorfer, U | 1 |
| Amadori, D; Conte, PF; Falcone, A; Gardin, G; Gentilini, P; Nicolin, A; Pronzato, P; Rosso, R; Rubagotti, A; Sismondi, P | 1 |
| Alama, A; Amadori, D; Conte, PF; Demicheli, R; Gardin, G; Gentilini, P; Jacomuzzi, A; Lionetto, R; Pronzato, P; Rubagotti, A | 1 |
| Amadori, D; Baldini, E; Brema, F; Gardin, G; Monzeglio, C; Naso, C; Pastorino, G; Pronzato, P; Rosso, R; Rubagotti, A | 1 |
| Bertelli, G; Bruzzi, P; Del Mastro, L; Garrone, O; Guelfi, M; Pastorino, S; Rosso, R; Sertoli, MR; Venturini, M | 1 |
| Chao, D; Harland, SJ | 1 |
| Denis, L | 1 |
5 trial(s) available for diethylstilbestrol and epirubicin
| Article | Year |
|---|---|
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis | 1987 |
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Random Allocation; Statistics as Topic | 1987 |
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Diethylstilbestrol; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasm Staging | 1993 |
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Topics: Adult; Aged; Analysis of Variance; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diethylstilbestrol; Disease Progression; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged | 1996 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
3 other study(ies) available for diethylstilbestrol and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hormonal chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Epirubicin; Humans; Ifosfamide; Male; Orchiectomy; Prostatic Neoplasms | 1989 |
The importance of continued endocrine treatment during chemotherapy of hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diethylstilbestrol; Disease Progression; Epirubicin; Fluorouracil; Goserelin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms | 1997 |